ASCO 2019 Lung Cancer: 36 Oral Presentations of the ASCO19 lung cancer track summarised
i don't do bad sauce passes
I'd rather be in outer space 🛸
we're not kids anymore.

祝日 / Permanent Vacation

pixel skylines
art blog(derogatory)
AnasAbdin

tannertan36
Aqua Utopia|海の底で記憶を紡ぐ
$LAYYYTER
Cosmic Funnies

Product Placement

#extradirty
Show & Tell
"I'm Dorothy Gale from Kansas"

Kiana Khansmith

Janaina Medeiros
NASA

seen from Estonia
seen from Belarus
seen from United States

seen from United States
seen from United States
seen from Malaysia
seen from Türkiye
seen from Germany

seen from Belarus

seen from T1

seen from Belgium

seen from United States

seen from United States
seen from United States
seen from United States
seen from United States

seen from United States
seen from T1
seen from Malaysia
seen from Malaysia
@medipaper
ASCO 2019 Lung Cancer: 36 Oral Presentations of the ASCO19 lung cancer track summarised

Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Venetoclax FDA approved for CLL and SLL
Ramucirumab FDA approved for hepatocellular carcinoma
FDA approves avelumab plus axitinib for renal cell carcinoma
T-DM1 FDA approved for early breast cancer

Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Ivosidenib FDA-approved as first-line treatment for AML patients with IDH1 mutation
Palbociclib approved for the treatment of male breast cancer
Atezolizumab +/- cobimetinib vs regorafenib for previously treated metastatic colorectal cancer (IMblaze370)
Happy Chinese New Year 2019
Happy Chinese New Year 2019

Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Trastuzumab-biosimilar Ontruzant® FDA approved in several indications
ERAS guidelines for antenatal and preoperative care in caesarean delivery
Cabozantinib FDA approved in HCC patients failing sorafenib
Erasmus University MC investigating a new surgical matrix to reduce post-operative complications
Keytruda® FDA approved for recurrent and metastatic Merkel cell carcinoma

Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
Calaspargase pegol-mknl (Asparlas®) FDA approved in paediatric and young adult acute lymphoblastic leukaemia (ALL) patients
It is thought that immune-checkpoint inhibitors could exacerbate chronic hepatitis B and C by enhancing T-cell cytotoxicity to viral antigens. The effects of PD-1, PD-L1 and CTLA4 inhibitors on HBV and HCV have largely been unreported. Most studies with I-O drugs excluded patients with chronic viral hepatitis. However, recent trials investigating I-O in HCC included subjects who were known hepatitis B and C carriers.
I-O in Special Populations: Chronic Viral Hepatitis Carriers https://medipr.org/2QwU1ps #BMS #Bristol-MyersSquibb #CTLA4 #HBV #HCV #hepatitis #I-O #nivolumab #Opdivo #PD-1